Opko Health (OPK) Depreciation & Amortization (CF) (2010 - 2026)

Opko Health has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $22.2 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 5.48% year-over-year to $22.2 million; the trailing twelve-month figure through Mar 2026 stood at $90.3 million (up 25.81% YoY), and the FY2025 full-year result was $91.6 million, down 6.67% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $22.2 million, down from $22.4 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $28.0 million in Q2 2022, with the low at $22.2 million in Q1 2026.
• Historically, Depreciation & Amortization (CF) has averaged $25.2 million across 5 years, with a median of $25.9 million in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 47.63% — and 2025, when it slipped 9.04%.
• Opko Health's Depreciation & Amortization (CF) stood at $26.5 million in 2022, then slipped by 1.81% to $26.0 million in 2023, then fell by 7.0% to $24.2 million in 2024, then retreated by 7.41% to $22.4 million in 2025, then decreased by 0.77% to $22.2 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $22.2 million (Q1 2026), $22.4 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.